Two SPARK-BIH funded teams network with investors and the life science industry at the international JPM BIO Partnering Event.Read more
We wish you SPARKling holidays and a good start in a successful new year!Read more
Can the neurological consequences of chemotherapy be prevented?
SPARK-BIH and BMBF-funded PREPARE study investigates protective effect of lithium in breast cancer patients.
In October 2022, Dr. Tanja Rosenmund, head of SPARK-BIH, together with her team welcomed fourteen new projects to the SPARK-BIH program. She and her team are excited to support the new SPARKees to translate their innovation from bench to bedside.Read more
We are happy to share the new High-Tech Gründerfonds podcast about SPARK-BIHRead more
VDI/VDE Innovation Interview with EpiBlock founder and SPARK alumni Prof. Heilbronn
Newly founded company of SPARK team MyoPax receives 1.3 million Euro loanRead more
Thank you for participating in our 2022 SPARK-BIH Call and NeuroCure/SPARK Call sessionsRead more
Charité neuroscientist Prof. Dr. Surjo Soekadar awarded with ERC Proof of Concept (ERCPoC) grant after NeuroCure/SPARK-BIH fundingRead more
EpiBlok Therapeutics GmbH is developing a gene therapy for epilepsyRead more